Entrepreneur Briefs

Wraparound Video The Small Business Innovations Research program is funding a project that could revolutionize the way people watch video images: the Alternate Reality Vision System (ARVIS), developed by an engineering firm in Conway, Wash. According to Bob Dyer, an electronics engineer at Concept Vision System, ARVIS is a stereoscopic image projection device that occupies the viewer's entire field of vision. Conceived by company president John Webster, a registered-nurse- turned-inventor who i

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Wraparound Video
The Small Business Innovations Research program is funding a project that could revolutionize the way people watch video images: the Alternate Reality Vision System (ARVIS), developed by an engineering firm in Conway, Wash. According to Bob Dyer, an electronics engineer at Concept Vision System, ARVIS is a stereoscopic image projection device that occupies the viewer's entire field of vision. Conceived by company president John Webster, a registered-nurse- turned-inventor who incorporated the firm last fall, the system projects images on two concave fiberoptic surfaces placed 3 centimeters from each eye and offers a view 120 degrees up and down and 240 degrees across, which is what people normally see. Working on a $429,000 Small Business Innovations Research contract from the Defense Advanced Research Projects Agency, Webster and Dyer hope to have their Phase II prototype ready by this fall.

DARPA hopes pilots will someday use the ARVIS technology and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies